Cav1.3 inhibitor (proposed)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cav1.3 inhibitor (proposed), covering 2024-07-08 to 2024-07-08. Get the full timeline:
Most recent: Clinical Trial Update: Effect of a Proposed Cav1.3 Inhibitor in Primary Aldosteronism [NA]